Bioxcel Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $38k | 13k | 2.95 |
| 2023-09-30 | $32k | 13k | 2.53 |
| 2023-06-30 | $143k | 21k | 6.66 |
| 2023-03-31 | $49k | 2.6k | 18.54 |
| 2022-12-31 | $221k | 12k | 19.05 |
| 2022-06-30 | $157k | 10k | 15.15 |
| 2022-03-31 | $284k | 14k | 20.91 |
| 2021-12-31 | $238k | 12k | 20.31 |
| 2021-03-31 | $320k | 8.2k | 38.96 |
| 2020-12-31 | $279k | 5.8k | 48.00 |
| 2020-09-30 | $0 | 4.4k | 0.00 |
| 2020-06-30 | $0 | 3.6k | 0.00 |
| 2020-03-31 | $50k | 2.2k | 22.54 |
| 2019-12-31 | $133k | 9.1k | 14.58 |
| 2019-09-30 | $14k | 2.0k | 7.08 |
| 2019-06-30 | $18k | 1.7k | 10.87 |